Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04356261 · ClinicalTrials.gov registry record · NA
Revolutionizing Normative Re-education
A NA study, sponsored by Loyola Marymount University.
- Completed
- Registry status
- NA
- Development phase
- 1,143
- Enrollment target
NCT04356261: Completed NA study, sponsored by Loyola Marymount University.
NCT04356261 is a NA study that has completed, run by Loyola Marymount University. The registered enrollment target is 1,143 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04356261, a NA study, has completed, sponsored by Loyola Marymount University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,143 participants
- Enrollment target
Study Summary
Personalized Normative Feedback (PNF), the most widely-used college alcohol intervention approach, suffers from several limitations innovatively remedied in the current proposal through CampusGANDR, a smartphone-based app for college students that delivers alcohol-related PNF within a weekly game centered around testing first-year students' perceptions about the attitudes and behaviors of their peers in a variety of campus-relevant domains. Five pilot studies suggest that CampusGANDR will be significantly more effective at correcting students' normative misperceptions and reducing their alcohol use than standard PNF, especially among heavier-drinking students and those with greater exposure to alcohol on social media, and that these larger effects are driven by the significantly decreased psychological reactance experienced by students when viewing feedback as part of a game about college life rather than as part of an alcohol-focused program. The current project seeks to 1) evaluate the efficacy of CampusGANDR in a large-scale multi-site trial, 2) identify the optimal dosage of alcohol feedback to deliver within CampusGANDR for correcting norms and reducing alcohol use across 12 weeks of gameplay among non-drinking, moderate-drinking, and heavy-drinking students, 3) examine person-level moderators of these effects, and 4) evaluate CampusGANDR engagement and sustainability among students who play voluntarily but are not involved in the randomized controlled trial.
Primary Outcome
The Daily Drinking Questionnaire assessess the number of drinks consumed per week in a typical week over the past three months.
Interventions
- BEHAVIORAL Gamified Personalized Normative Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,143 participants |
| Start Date | 2021-08-15 |
| Est. Completion | 2024-10-25 |
| Phase | NA |
What the finished NCT04356261 record still lists
NCT04356261 is an interventional study that assigns participants to a tested intervention. Its 1,143 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 1 intervention - of which Gamified Personalized Normative Feedback is the first listed.
NCT04356261 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04356261 about?
NCT04356261 is a clinical study titled "Revolutionizing Normative Re-education". Personalized Normative Feedback (PNF), the most widely-used college alcohol intervention approach, suffers from several limitations innovatively remedied in the current proposal through CampusGANDR, a smartphone-based app for college students that delivers alcohol-related PNF within a weekly game ce...
What is the current status of trial NCT04356261?
This trial is currently completed. It is a NA study. The enrollment target is 1,143 participants. The study started on 2021-08-15. Estimated completion is 2024-10-25.
What interventions are being tested in trial NCT04356261?
The interventions under investigation include: Gamified Personalized Normative Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT04356261?
This trial is sponsored by Loyola Marymount University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04356261's enrollment target sits among peer trials
1,143 92nd of 2000 higher than 1,909 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI